Skip to content
MamaGLP — home
Menu

Evidence review

GLP-1 for Endometriosis: What We Actually Know (and Don't)

Can GLP-1 meds help endometriosis? An honest, well-cited look at the thin, emerging evidence — no hype, just what the research really says.

Written by Camila Rael, editor

Research checked by Beatriz Lang, our evidence reviewer — a former pharma-industry analyst (a disclosed pen name), not a clinician who treats you. What follows is friendly information, never medical advice.

The honest short answer

I want to be straight with you from the first line, because this is a place where a lot of the internet is not: **there is no good evidence yet that GLP-1 medications treat endometriosis.** They are not approved for it, there are no large trials showing they shrink lesions or relieve endometriosis pain, and any claim otherwise is getting ahead of the science. What *does* exist is a small, early, mostly indirect trail of research — and I would rather walk you through that honestly than sell you a hope that isn't grounded yet.

Why people even ask the question

Endometriosis is a chronic condition where tissue similar to the uterine lining grows outside the uterus, often causing pain and affecting fertility. It is increasingly understood as an inflammatory and, in some women, a metabolically-linked condition1. Because GLP-1 medicines calm some inflammatory and metabolic pathways and are being explored across gynecology3, it is a reasonable question to ask. Reasonable to ask is not the same as answered, though.

The nuance almost no one tells you: weight and endometriosis are not a simple story

With PCOS, the logic is clean — weight and insulin resistance drive a lot of it, so weight loss helps. Endometriosis is different, and this surprises people. In a meta-analysis of body-mass index and endometriosis, higher BMI was actually associated with *lower* endometriosis risk, not higher2. So you cannot simply borrow the "GLP-1 helps you lose weight, therefore it helps the condition" argument from the PCOS playbook. The relationship between metabolic health and endometriosis is real but tangled — some studies do link endometriosis with features of metabolic syndrome5 — and it does not map neatly onto weight loss.

What early biology hints at

Here is the genuinely interesting, genuinely preliminary part. One study measuring hormones in the pelvic (peritoneal) fluid of women with endometriosis found that GLP-1 levels were lower there compared with women without the condition, alongside other changes in inflammatory and metabolic markers4. That is a fascinating clue about GLP-1 signaling being altered in endometriosis — but it is a small observational finding about the body's *own* GLP-1, not evidence that a GLP-1 medication changes the disease. Please hold it loosely.

What the reviewers say out loud

The most current gynecology reviews put it plainly: research into GLP-1 medications for conditions beyond PCOS — including infertility and endometrial hyperplasia — is *ongoing*, and further studies are needed before any recommendations can be made3. A broader review of medical therapy to support metabolic health and fertility in reproductive-aged women echoes that GLP-1 medicines are a promising area still being defined, not a settled treatment6. In other words: interesting, unproven, watch this space.

So what can a GLP-1 actually do right now?

What these medicines are genuinely proven to do is help with weight and blood sugar7. If you have endometriosis *and* a separate reason a clinician would consider a GLP-1 — like weight management or type 2 diabetes — that is a real, evidence-based use, and endometriosis does not automatically rule it out. But that is treating the other condition, not the endometriosis itself. And as always, these medicines are **not used during pregnancy or while trying to conceive**, which matters a lot in a condition so tied to fertility8.

A calm next step

If you live with endometriosis, the people to steer this are a gynecologist who knows your case and, if weight or metabolic health is also on the table, a clinician who can weigh a GLP-1 for *that* reason. When you want to understand what an honest program looks like without pressure, our top pick CoreAge Rx is a gentle place to see the standard of care, and you can compare every program we scored on the best GLP-1 for moms board. If fertility is part of your story, GLP-1 and fertility is worth reading next. You deserve information that respects how little is settled here. — Camila

*This guide is educational only and is not medical advice.*

Frequently asked questions

Do GLP-1 medications treat endometriosis?

No. There is no good evidence that GLP-1 medicines treat endometriosis, and they are not approved for it. There are no large trials showing they reduce lesions or endometriosis pain. Existing research is early, small, and mostly indirect.

Does losing weight with a GLP-1 help endometriosis?

Not in a straightforward way. Unlike PCOS, endometriosis is not clearly driven by higher weight — in fact, meta-analysis data associate higher BMI with lower endometriosis risk. So the weight-loss rationale that works for PCOS does not simply carry over.

Could I still take a GLP-1 if I have endometriosis?

Possibly, but for a different reason. If you also have a clinician-supported reason like weight management or type 2 diabetes, having endometriosis does not automatically rule out a GLP-1. That treats the other condition, not the endometriosis. It is a decision to make with your clinician, and these medicines are not used while trying to conceive.

References

  1. Desai SN, et al. (2026). The Hidden Link Between Endometriosis and Obesity: A State-of-the-Art Review. Cureus. https://pubmed.ncbi.nlm.nih.gov/41798441/
  2. Liu Y, Zhang W. (2017). Association between body mass index and endometriosis risk: a meta-analysis. Oncotarget. https://pubmed.ncbi.nlm.nih.gov/28159926/
  3. Howard MD, Allen SE. (2025). The use of GLP-1 receptor agonist medications for benign gynecology. Current Opinion in Obstetrics & Gynecology. https://pubmed.ncbi.nlm.nih.gov/40183300/
  4. Krasnyi AM, Sadekova AA, Smolnova TY, et al. (2022). The Levels of Ghrelin, Glucagon, Visfatin and GLP-1 Are Decreased in the Peritoneal Fluid of Women with Endometriosis. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/36142272/
  5. Li B, et al. (2023). Association between endometriosis and metabolic syndrome: a cross-sectional study. Gynecological Endocrinology. https://pubmed.ncbi.nlm.nih.gov/37673102/
  6. Duah J, Seifer DB. (2025). Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review. Reproductive Biology and Endocrinology. https://pubmed.ncbi.nlm.nih.gov/39762910/
  7. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/
  8. Nuako A, Tu L, Reyes KJC, et al. (2023). Pharmacologic Treatment of Obesity in Reproductive Aged Women. Current Obstetrics and Gynecology Reports. https://pubmed.ncbi.nlm.nih.gov/37427372/

Friendly information, not a prescription. Everything on MamaGLP is here to help you understand your options and ask better questions — it isn't a diagnosis, a treatment plan, or a nudge to start or stop anything. Only a licensed clinician who knows your history and your goals can tell you what's right for you, so please loop one in before you act on a word of it.

Continue reading